Projects per year
Personal profile
Fingerprint
Dive into the research topics where Amar Balihodzic is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Identfying novel vulnerabilites in lung cancer utlizing advanced CRISPR approaches
Balihodzic, A. (Principal investigator)
1/09/25 → 31/08/27
Project: Research funding
-
Using dual CRISPRko and CRISPRa screens to identify novel targets to overcome cancer drug resistance
Dengler, M. (Principal investigator), Flasch, B. (Co-investigator) & Balihodzic, A. (Co-investigator)
1/01/22 → 31/12/24
Project: Research funding
-
RNADIAGON: Excellence in research and development of non-coding RNA DIAGnostics in ONcology
Pichler, M. (Principal investigator), Resel, M. (Co-investigator), Huber, K. (Co-investigator), Ruggieri, F. (Co-investigator), Barth, D. A. (Co-investigator) & Balihodzic, A. (Co-investigator)
1/02/19 → 31/07/24
Project: Research funding
-
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer.
Balihodzic, A., Fernandez Hernandez, F. J., Jäger, V., Vosberg, S., Schnur, T., Kainz, G., Gallé, B., Schweintzger, N., Kühberger, S., Heitzer, E., Reinisch, A., Jost, P., Pichler, M. & Dengler, M., 2023.Research output: Contribution to conference book › Conference article
-
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
Egger, V., Hutterer, G., Mischinger, J., Seles, M., Pichler, R., Mannweiler, S., Huber, K., Balihodzic, A., Spiegelberg, J. A., Bauernhofer, T., Ahyai, S., Zigeuner, R., Pichler, M. & Barth, D. A. (Last author), May 2023, In: World Journal of Urology. 41, 5, p. 1359-1364 6 p.Research output: Contribution to journal › Research article
5 Citations (Web of Science) -
The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge-A Systematic Review.
Perdyan, A., Sobocki, B., Balihodzic, A., Dąbrowska, A., Kacperczyk, J. & Rutkowski, J., 4 Jul 2023, In: Cancers. 15, 13, 20 p., 3490.Research output: Contribution to journal › Research article
26 Citations (Web of Science) -
The Role of Regulatory T Cells in Cancer Treatment Resistance.
Dąbrowska, A., Grubba, M., Balihodzic, A., Szot, O., Sobocki, B. & Perdyan, A., 14 Sept 2023, In: International Journal of Molecular Sciences. 24, 18, 20 p., 14114.Research output: Contribution to journal › Review
20 Citations (Web of Science) -
A novel long non-coding RNA hypoxia associated-lncRNA1 is involved in cellular growth, apoptosis and patients’ prognosis in clear cell renal cell carcinoma.
Balihodzic, A., Prinz, F., Jonas, K., Barth, D. A., Dengler, M., Slaby, O., Jost, P., Klec, C. & Pichler, M., 2022.Research output: Contribution to conference book › Conference article
-
CRISPR/Cas9 screening for cancer drivers in NSCLC
Balihodzic, A. (Speaker)
2024Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
BCL-XL plays a role in determining lung cancer cell fate upon chemotherapy
Balihodzic, A. (Speaker), Jäger, V. (Author), Reinisch, A. (Author), Jost, P. (Author), Strasser, A. (Author) & Dengler, M. (Author)
2024Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Identifying synthetic lethal interactions with MCL-1 inhibition in lung cancer.
Balihodzic, A. (Speaker)
2023Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer
Balihodzic, A. (Speaker), Fernandez Hernandez, F. J. (Author), Jäger, V. (Author), Vosberg, S. (Author), Tonietto, M. (Author), Schnur, T. (Author), Kainz, G. (Author), Gallé, B. (Author), Schweintzger, N. (Author), Kühberger, S. (Author), Heitzer, E. (Author), Reinisch, A. (Author), Jost, P. (Author), Pichler, M. (Author) & Dengler, M. (Author)
2023Activity: Talk, presentation or poster › Poster
-
Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer.
Balihodzic, A. (Speaker), Fernandez Hernandez, F. J. (Author), Jäger, V. (Author), Vosberg, S. (Author), Schnur, T. (Author), Kainz, G. (Author), Gallé, B. (Author), Schweintzger, N. (Author), Kühberger, S. (Author), Heitzer, E. (Author), Reinisch, A. (Author), Jost, P. (Author), Pichler, M. (Author) & Dengler, M. (Author)
2023Activity: Talk, presentation or poster › Scientific talk or presentation › On site